MMP2 mRNA expression level is suggested to contribute to the aggressiveness of cholesteatoma, and thus, MMP2 inhibition may be a therapeutic option for cases featuring MMP2 upregulation. This evidence concerns the gene MMP2 and cholesteatoma.